Joshua Brown

Joshua Brown, Pharm.D., Ph.D., M.S.

Assistant Professor

Department: Pharmaceutical Outcomes & Policy
Business Phone: (352) 294-8593
Business Email:

About Joshua Brown

Joshua Brown joined the Department of Pharmaceutical Outcomes and Policy as an assistant professor in 2016. He has experience in clinical pharmacy, health economics and outcomes research, and pharmacoepidemiology across academic, pharmaceutical industry, and managed care. His past and ongoing clinical interests have been in the cardiovascular and hematology/oncology therapeutic areas including comparative effectiveness and safety research with a focus on anticoagulation and quality of care in thrombotic conditions such as atrial fibrillation, venous thromboembolism, and cancer. His current research program and collaborations focus on research methods for pharmacoepidemiologic and pharmacoeconomic generic and biosimilar evaluations, developing real-world evidence for drug-drug interactions, and drug repurposing studies (e.g. aging and Parkinson’s Disease). \His academic work has been funded by the NIH, FDA, Bill & Melinda Gates Foundation, and the PhRMA Foundation in addition to contracts with pharmaceutical industry. Josh has published over 100 research articles and holds several editorial positions with high impact specialty journals in pharmacy and cardiovascular diseases and is actively involved in AMCP, ISPE, and ISPOR scientific societies. Dr. Brown was awarded as the AMCP Foundation’s “New Practitioner” for his early career contributions to managed care pharmacy.


New Practitioner Award
2019 · Academy of Managed Care Pharmacy
Emerging Leader
2019 · National Academy of Medicine
Loan Repayment Program
2018-2020 · NIH – National Institute on Aging
Claude D. Pepper Junior Scholar
2017-2019 · UF Institute on Aging


2020 CPT: pharmacometrics & systems pharmacology
2020 International Journal of Environmental Research and Public Health


Oct 2019 – Sep 2020
Quality of care for inferior vena cava filters at UF Health Shands Hospital
UF HEALTH SHANDS HOSPITAL · Principal Investigator
Jul 2019 ACTIVE
Consortium for Medical Marijuana Clinical Outcomes Research
Nov 2017 ACTIVE
Application of physiologically-based pharmacokinetic models to inform dosing recommendations for hormonal contraceptives co-administered with other medications
Sep 2017 – Feb 2019
Comparative effectiveness of direct-acting oral anticoagulants (DOACs) for stroke prevention in atrial fibrillation: Influence of study methods on the usefulness of the results in the real-world
PHRMA FOU · Principal Investigator
Sep 2014 – Aug 2018
A Model- and Systems-based Approach to Efficacy and Safety Questions Related to Generic Substitution


2016 · University of Kentucky
2014 · University of Arkansas for Medical Science
2014 · University of Arkansas for Medical Science
2010 · University of Arkansas

Contact Details

(352) 294-8593

Recent news

UF researchers report mixed results in safety study of drugs seen as possible COVID-19 therapeutics

University of Florida College of Pharmacy researchers studying the safety of two classes of drugs touted as potential therapeutics for COVID-19 report mixed results.

UF leadership in the International Society for Pharmacoepidemiology

UF Faculty and alumni took over several leadership roles in the society during the 35th International Conference on Pharmacoepidemiology in Philadelphia.   Along with Dr. Almut Winterstein, Dr. Juan Hincapie-Castillo also…

Study finds moderate reduction carisoprodol use following DEA Schedule IV classification

UF researchers reviewed more than 13 million patients using carisoprodol, a powerful muscle relaxant.

Dr. Josh Brown receives AMCP’s 2019 New Practitioner Award

AMCP gives the award to a member who has made a significant contribution to managed care pharmacy within five years of graduation.